These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 9240728)

  • 1. Optimizing Thyroxine Dosage After Total Thyroidectomy: Understanding the Factors at Play.
    Dawn Paul E; T V S; Sulaiman SV
    Cureus; 2024 Apr; 16(4):e58430. PubMed ID: 38765445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of high-dose Levothyroxine on hearing in patients operated for thyroid cancer.
    Mutlu V; Kaya Z; Bilen A; Dayanan R
    Eur Arch Otorhinolaryngol; 2024 Jul; ():. PubMed ID: 39083061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Age, Sex and Transfusion Affects the Incidence of Endocrine and Bone Density Disorders in Major Thalassemic Patients.
    Mohajeri-Tehrani MR; Alemzadeh SA; Marzbali FA; Nasserisina S; Hosnan F; Naghghash A; Hamidieh AA; Behfar M; Mohseni F; Rashidian H; Shirazi S; Aboee-Rad M; Qorbani M; Larijani B; Hamidi Z
    Iran J Public Health; 2024 Feb; 53(2):433-442. PubMed ID: 38894828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Suppressive Levothyroxine Therapy on Bone Mineral Density in Young Patients with Differentiated Thyroid Carcinoma.
    Zanella AB; Marmitt L; Fighera TM; Scheffel RS; Spritzer PM; Dora JM; Maia AL
    Metabolites; 2022 Sep; 12(9):. PubMed ID: 36144246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSH suppressive therapy and bone.
    Brancatella A; Marcocci C
    Endocr Connect; 2020 Jul; 9(7):R158-R172. PubMed ID: 32567550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Osteoporosis and Fractures in Patients with Thyroid Cancer: A Case-Control Study in U.S. Veterans.
    Papaleontiou M; Banerjee M; Reyes-Gastelum D; Hawley ST; Haymart MR
    Oncologist; 2019 Sep; 24(9):1166-1173. PubMed ID: 31164453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Thyrotropin Suppression Therapy on Bone in Thyroid Cancer Patients.
    Papaleontiou M; Hawley ST; Haymart MR
    Oncologist; 2016 Feb; 21(2):165-71. PubMed ID: 26659220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Levothyroxine and thyroid stimulating hormone on bone loss in patients with primary hypothyroidism.
    Karimifar M; Esmaili F; Salari A; Kachuei A; Faragzadegan Z; Karimifar M
    J Res Pharm Pract; 2014 Jul; 3(3):83-7. PubMed ID: 25328897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone disease in thyrotoxicosis.
    Reddy PA; Harinarayan CV; Sachan A; Suresh V; Rajagopal G
    Indian J Med Res; 2012 Mar; 135(3):277-86. PubMed ID: 22561612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma.
    Reverter JL; Colomé E; Holgado S; Aguilera E; Soldevila B; Mateo L; Sanmartí A
    Endocrine; 2010 Jun; 37(3):467-72. PubMed ID: 20960170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling the effect of levothyroxine therapy on bone mass density in postmenopausal women: a different approach leads to new inference.
    Mohammadi B; Haghpanah V; Tavangar SM; Larijani B
    Theor Biol Med Model; 2007 Jun; 4():23. PubMed ID: 17559682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative correlation between bone mineral density and TSH receptor antibodies in male patients with untreated Graves' disease.
    Majima T; Komatsu Y; Doi K; Takagi C; Shigemoto M; Fukao A; Morimoto T; Corners J; Nakao K
    Osteoporos Int; 2006; 17(7):1103-10. PubMed ID: 16601919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of osteoporosis.
    Samelson EJ; Hannan MT
    Curr Rheumatol Rep; 2006 Feb; 8(1):76-83. PubMed ID: 16515770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary thyroid cancer: medical management and follow-up.
    Kloos RT
    Curr Treat Options Oncol; 2005 Jul; 6(4):323-38. PubMed ID: 15967085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical thyroid disorders: the menace of the Trojan horse.
    Duntas LH
    J Endocrinol Invest; 2003 May; 26(5):472-80. PubMed ID: 12906377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects of thyroid hormones.
    Williams JB
    Drugs Aging; 1997 Dec; 11(6):460-9. PubMed ID: 9413703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.
    Marcocci C; Golia F; Vignali E; Pinchera A
    J Bone Miner Res; 1997 Jan; 12(1):72-7. PubMed ID: 9240728
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.